mo

Molina Healthcare

MOH
NYSE
$149.74

Does Molina Healthcare have a strong competitive moat?

Molina Healthcare's moat score of 34 out of 100 reflects the inherent challenges in establishing truly dominant, defensible advantages within the highly regulated and competitive managed healthcare industry.

While Molina's significant scale, with TTM Revenue of $97.92B, suggests a broad operational footprint, competitive advantages often derive from efficient provider networks, strong relationships with state governments for Medicaid contracts, and cost leadership in processing claims.

However, these advantages can be tenuous, subject to policy changes, new market entrants, or competitive bidding processes. The industry typically operates with thin margins, as evidenced by Molina's TTM Net Margin of 2.5% and TTM Operating Margin of 3.6%, which limits the ability to generate outsized returns that would signify a powerful moat.

While a large member base and provider network do create some barriers to entry, they are not insurmountable, justifying a moderate yet not exceptional moat assessment for the company.